Your Article Summary
See Latest ArticlesAnti-B-cell strategies in vasculitides and collagenoses
Zeitschrift für Rheumatologie, 06/26/09
Rubbert-Roth A - The feasibility of targeting B-cells in patients with severe and refractory autoimmune disorders, especially in patients with vasculitis or connective tissue diseases, has met growing interest among rheumatologists in recent years. The use of rituximab as a monoclonal antibody directed against CD20 positive B-cells has been reported in case reports and small patient series; however, these are hard to compare as different diseases are described and different doses and schedules of rituximab were used.
Today in Autoimmune/Heritable...keeping you current
Receive free subspecialty "5-minute updates" via email
Lymphatic and blood vessels in scleroderma skin, a morphometric analysis
Human Pathology, 12/16/09
Brain magnetic resonance imaging findings in patients with systemic sclerosis
International Journal of Rheumatic Diseases, 12/15/09
Gastrointestinal manifestation of systemic sclerosis—thickening of the upper gastrointestinal wall detected by endoscopic ultrasound is a valid sign
Rheumatology, 12/15/09